Drug Shortage Report for FASTURTEC
Report ID | 193234 |
Drug Identification Number | 02248416 |
Brand name | FASTURTEC |
Common or Proper name | FASTURTEC |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | RASBURICASE |
Strength(s) | 1.5MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 3 vials |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-05-26 |
Actual start date | 2023-05-25 |
Estimated end date | 2023-09-29 |
Actual end date | 2023-10-03 |
Shortage status | Resolved |
Updated date | 2023-10-04 |
Company comments | Health Canada has allowed the temporary importation and distribution of Great Britain –labelled product. Lot No. 3J1011, Expiry Date:28.02.2026, PLGB 04425/0821 Please contact LAVALCS@sanofi.com in case of questions. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2023-10-04 | English | Compare |
v14 | 2023-10-03 | French | Compare |
v13 | 2023-10-03 | English | Compare |
v12 | 2023-10-03 | French | Compare |
v11 | 2023-10-03 | English | Compare |
v10 | 2023-09-19 | French | Compare |
v9 | 2023-09-19 | English | Compare |
v8 | 2023-07-21 | French | Compare |
v7 | 2023-07-21 | English | Compare |
v6 | 2023-06-09 | French | Compare |
v5 | 2023-06-09 | English | Compare |
v4 | 2023-06-09 | French | Compare |
v3 | 2023-06-09 | English | Compare |
v2 | 2023-05-26 | French | Compare |
v1 | 2023-05-26 | English | Compare |
Showing 1 to 15 of 15